Review Audit Trails of Electronic Records as Part of GMP Oversight

Routinely Review Audit Trails to Ensure Electronic Record Integrity

Remember: Audit trails must be periodically reviewed by QA or authorized personnel to detect data changes and uphold GMP data integrity standards.

Why This Matters in GMP

Electronic records are widely used in pharmaceutical operations, from batch processing and laboratory systems to cleaning validations and calibration logs. Audit trails record who accessed data, what was changed, and when the action occurred. Without review, unauthorized data s, deletions, or late entries may go unnoticed—violating ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, and others). Regulators expect audit trails to be enabled, locked, and reviewed at defined intervals. This practice strengthens trust in electronic data, enables robust root cause investigations, and supports compliant batch release.

Also Read: Alert QA Before Flushing Drain Systems to Avoid GMP Compliance Issues

Regulatory and Compliance Implications

FDA 21 CFR Part 11 mandates secure audit trails for electronic records, with access controls and timestamp accuracy. EU GMP Annex 11 emphasizes routine review of audit logs as part of system validation and oversight. WHO GMP and Schedule M align with these requirements by insisting on audit trail functionality and review by independent personnel. Regulatory inspectors check whether audit trails are active, tamper-proof, and periodically reviewed with

documented evidence. Failure to do so often leads to data integrity warnings, observations, and compliance risks during electronic system validation audits.

Implementation Best Practices

Enable audit trail functionality in all GMP-relevant electronic systems including LIMS, HPLC, BMS, and MES platforms.
Define SOPs for routine review frequency, reviewer qualifications, and documentation of observations.
Train QA staff to identify unusual patterns or unauthorized access attempts.
Secure systems with role-based access to ensure only authorized s can be made.
Ensure audit trail reviews are part of batch review, deviation investigations, and system requalification activities.

Also Read: Pre-Use Post-Sterilization Integrity Testing (PUPSIT): Practical Implementation

Regulatory References

FDA 21 CFR Part 11 – Electronic Records and Audit Trails
EU GMP Annex 11 – Computerized Systems Audit Trail Review
WHO GMP – Data Integrity and Computerized Systems
Schedule M – Electronic Data and Audit Trail Management